<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36354298</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1576-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>Revista de neurologia</Title><ISOAbbreviation>Rev Neurol</ISOAbbreviation></Journal><ArticleTitle>[Analysis of accidental falls and the integration in the chronicity programs of patients with amyotrophic lateral sclerosis].</ArticleTitle><Pagination><StartPage>297</StartPage><EndPage>303</EndPage><MedlinePgn>297-303</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33588/rn.7510.2022327</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic lateral sclerosis (ALS) is the most common degenerative motor neuron disease. There is no curative treatment available, and these patients require multidisciplinary support to promote their comfort and quality of life.</AbstractText><AbstractText Label="PATIENTS AND METHODS">Longitudinal descriptive study in patients registered in primary care (PC), Costa de Ponent-Barcelona Institut Catala de la Salut to analyse emergency hospital visits, use of support devices and their integration into the primary care chronicity program. Variables were sex, age and evolution time, emergency visits, patients with percutaneous gastrostomy (PEG), non-invasive or invasive ventilation (NIV/VI), integration in the primary care chronicity program.</AbstractText><AbstractText Label="RESULTS">81 patients, 49.4% male, mean age 65.6 years (&#xb1;11.7), evolution time less than 2 years or equal to or greater than 2 years (42 and 58%, respectively). Of them, 47 (58.5%) made 107 consultations. The most frequent reasons for consultation were falls (26.8%), respiratory difficulties (23.3%), comorbidity (16.7%), eating problems (11%) and pain (10.2%) without differences by age or sex. Greater frequency (p &lt; 0.001) was observed in patients with less than two years of evolution and significant increases in the use of NIV and PEG up to 51.9 and 35.8% respectively, as well as integration in primary care chronicity program of 61.7%.</AbstractText><AbstractText Label="CONCLUSIONS">Accidental falls were the most frequent and potentially avoidable reason for hospital emergency visits in patients with ALS, especially in the first two years of the disease. Significant increases are detected in the use of support devices and in primary care chronicity program integration. It is necessary to increase home resources, especially in physiotherapy and occupational therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castro-Rodr&#xed;guez</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PADES Delta de Llobregat. Institut Catal&#xe0; de la Salut, El Prat de Llobregat, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azagra-Ledesma</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Atenci&#xf3;n Primaria Bad&#xed;a del Vall&#xe8;s. Institut Catal&#xe0; de la Salut, Badia del Vall&#xe8;s, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GROIMAP. USR Metropolitana Nord-IDIAP Jordi Gol, Cerdanyola del Vall&#xe9;s, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n Privada PRECIOSA para la Investigaci&#xf3;n en Salud, Barber&#xe0; del Vall&#xe8;s, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Batiste Alert&#xf3;n</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Universitat de Vic-Universitat Central de Catalunya, Vic, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguy&#xe9;-Batista</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GROIMAP. USR Metropolitana Nord-IDIAP Jordi Gol, Cerdanyola del Vall&#xe9;s, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Atenci&#xf3;n Primaria Granollers Vall&#xe9;s Oriental. Institut Catal&#xe0; de la Salut, Granollers, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwart-Salmer&#xf3;n</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universitat de Girona, Girona, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Atenci&#xf3;n Primaria Can Gibert del Pla. Institut Catal&#xe0; de la Salut , Girona, Espa&#xf1;a.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GROIMAP. Unitat Suport a la Recerca (USR) Girona-IDIAP Jordi Gol, Girona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabanas-Vald&#xe9;s</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universitat Internacional de Catalunya, Sant Cugat del Vall&#xe8;s, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caballero-G&#xf3;mez</LastName><ForeName>F M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Hospital Universitari Parc Taul&#xed;, Sabadell, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clemente-Azagra</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Newcastle, Newcastle, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>An&#xe1;lisis de las ca&#xed;das accidentales y la integraci&#xf3;n en los programas de cronicidad de los pacientes con esclerosis lateral amiotr&#xf3;fica.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Neurol</MedlineTA><NlmUniqueID>7706841</NlmUniqueID><ISSNLinking>0210-0010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000058" MajorTopicYN="N">Accidental Falls</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063087" MajorTopicYN="Y">Noninvasive Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="TITLE">An&#xe1;lisis de las ca&#xed;das accidentales y la integraci&#xf3;n en los programas de cronicidad de los pacientes con esclerosis lateral amiotr&#xf3;fica.</AbstractText><AbstractText Label="UNLABELLED">Introducci&#xf3;n. La esclerosis lateral amiotr&#xf3;fica (ELA) es la enfermedad degenerativa de las motoneuronas m&#xe1;s frecuente. No dispone de tratamiento curativo y estos pacientes requieren un soporte multidisciplinar para favorecer su confort y calidad de vida. Pacientes y m&#xe9;todos. Estudio descriptivo longitudinal en pacientes registrados en atenci&#xf3;n primaria, Costa de Ponent-Barcelona, Institut Catal&#xe0; de la Salut, para analizar las visitas urgentes hospitalarias, la utilizaci&#xf3;n de dispositivos de soporte y su integraci&#xf3;n en el programa de atenci&#xf3;n a la cronicidad. Las variables fueron sexo, edad y tiempo de evoluci&#xf3;n, visitas urgentes, portadores de gastrostom&#xed;a percut&#xe1;nea (PEG), ventilaci&#xf3;n no invasiva o invasiva (VNI/VI) e integraci&#xf3;n en el programa de atenci&#xf3;n a la cronicidad. Resultados. Se incluy&#xf3; a 81 pacientes, un 49,4% varones, con una edad media de 65,6 a&#xf1;os (&#xb1;11,7), y un tiempo de evoluci&#xf3;n menor de 2 a&#xf1;os o igual o mayor de 2 a&#xf1;os (42 y 58%, respectivamente). De ellos, 47 (58,5%) realizaron 107 consultas. Los motivos de consulta m&#xe1;s frecuentes fueron: ca&#xed;das (26,8%), dificultades respiratorias (23,3%), comorbilidad (16,7%), problemas en la alimentaci&#xf3;n (11%) y dolor (10,2%), sin diferencias por edad o sexo. Se observ&#xf3; una mayor frecuentaci&#xf3;n (p menor de 0,001) en pacientes con menos de dos a&#xf1;os de evoluci&#xf3;n e incrementos significativos en la utilizaci&#xf3;n de la VNI y la PEG hasta el 51,9 y el 35,8%, respectivamente, as&#xed; como integraci&#xf3;n en el programa de atenci&#xf3;n a la cronicidad del 61,7%. Conclusiones. El motivo m&#xe1;s frecuente de consulta a urgencias hospitalarias de pacientes con ELA y potencialmente evitable fueron las ca&#xed;das accidentales, especialmente en los primeros dos a&#xf1;os de enfermedad. Se detectan incrementos significativos en la utilizaci&#xf3;n de dispositivos de soporte y en la integraci&#xf3;n en el programa de atenci&#xf3;n a la cronicidad. Es necesario incrementar los recursos domiciliarios, especialmente en fisioterapia y terapia ocupacional.</AbstractText></OtherAbstract><CoiStatement>Conflicto de intereses: Los autores declaran no tener conflictos de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36354298</ArticleId><ArticleId IdType="pmc">PMC10280769</ArticleId><ArticleId IdType="doi">10.33588/rn.7510.2022327</ArticleId><ArticleId IdType="pii">rn2022327</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2;A, Rix-Brooks B, Van den Berg LH. Amyotrophic lateral sclerosis:moving towards a new classification system. Lancet Neurol 2016;15:1182-94.</Citation><ArticleIdList><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, Van den Berg LH. Amyotrophic lateral sclerosis:moving towards a new classification system. Lancet Neurol. 2016;15:1182&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162-72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Gonzalo I, Ruiz-Soto M, Berziano J. &#xbf;Por qu&#xe9;degeneran las motoneuronas?Actualizaci&#xf3;n en la patogenia de la esclerosis lateral amiotr&#xf3;fica. Neurologia 2019;34:27-37.</Citation><ArticleIdList><ArticleId IdType="pubmed">26853842</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Gonzalo I, Ruiz-Soto M, Berziano J. &#xbf;Por qu&#xe9;degeneran las motoneuronas?Actualizaci&#xf3;n en la patogenia de la esclerosis lateral amiotr&#xf3;fica. Neurologia. 2019;34:27&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">26853842</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis:a meta-analysis. Int J Epidemiol 2017;46:57-74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis:a meta-analysis. Int J Epidemiol. 2017;46:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcel&#xf3;MA, Povedano M, V&#xe1;zquez-Costa JF, Franquet &#xc1;, Solans M, S&#xe1;ez M. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions:Catalonia and Valencia. Sci Rep 2021;11:6207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973725</ArticleId><ArticleId IdType="pubmed">33737526</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcel&#xf3; MA, Povedano M, V&#xe1;zquez-Costa JF, Franquet &#xc1;, Solans M, S&#xe1;ez M. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions:Catalonia and Valencia. Sci Rep. 2021;11:6207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973725</ArticleId><ArticleId IdType="pubmed">33737526</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Rodr&#xed;guez E, Azagra R, G&#xf3;mez-Batiste X, Povedano M. La esclerosis lateral amiotr&#xf3;fica (ELA) desde la atenci&#xf3;n primaria. Epidemiolog&#xed;a y caracter&#xed;sticas cl&#xed;nico-asistenciales. Aten Primaria 2021;53:102158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435918</ArticleId><ArticleId IdType="pubmed">34509895</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Rodr&#xed;guez E, Azagra R, G&#xf3;mez-Batiste X, Povedano M. La esclerosis lateral amiotr&#xf3;fica (ELA) desde la atenci&#xf3;n primaria. Epidemiolog&#xed;a y caracter&#xed;sticas cl&#xed;nico-asistenciales. Aten Primaria. 2021;53:102158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435918</ArticleId><ArticleId IdType="pubmed">34509895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol 2016;12:526-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2016;12:526&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw P, McDermott J. The natural history of motor neuron disease:assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:13-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22642305</ArticleId></ArticleIdList></Reference><Reference><Citation>Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw P, McDermott J. The natural history of motor neuron disease:assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:13&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22642305</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival:a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258-61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1738639</ArticleId><ArticleId IdType="pubmed">12933930</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival:a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003;74:1258&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1738639</ArticleId><ArticleId IdType="pubmed">12933930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 2006;77:948-50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077622</ArticleId><ArticleId IdType="pubmed">16614011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077622</ArticleId><ArticleId IdType="pubmed">16614011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J Neurol 2007;254:1107-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">17431705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. J Neurol. 2007;254:1107&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">17431705</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65:1264-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16247055</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65:1264&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16247055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng L, Khan F, Mathers S. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2009;4:CD007425.</Citation><ArticleIdList><ArticleId IdType="pubmed">19821416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng L, Khan F, Mathers S. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2009;4:CD007425.</Citation><ArticleIdList><ArticleId IdType="pubmed">19821416</ArticleId></ArticleIdList></Reference><Reference><Citation>Paipa AJ, Povedano M, Barcelo A, Dom&#xed;nguez R, S&#xe1;ez M, Tur&#xf3;n J, et al. Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain:association with noninvasive mechanical ventilation. J Multidiscip Healthc 2019;12:465-70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590410</ArticleId><ArticleId IdType="pubmed">31354285</ArticleId></ArticleIdList></Reference><Reference><Citation>Paipa AJ, Povedano M, Barcelo A, Dom&#xed;nguez R, S&#xe1;ez M, Tur&#xf3;n J, et al. Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain:association with noninvasive mechanical ventilation. J Multidiscip Healthc. 2019;12:465&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590410</ArticleId><ArticleId IdType="pubmed">31354285</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambl&#xe0;s-Novellas J, Murray A, Espaluella J, Martori JC. Identifying patients with advanced chronic conditions for a progressive palliative care approach:a crosssectional study of prognostic indicators related to end-of-life trajectories. BMJ Open 2016;6:e012340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5030552</ArticleId><ArticleId IdType="pubmed">27645556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambl&#xe0;s-Novellas J, Murray A, Espaluella J, Martori JC. Identifying patients with advanced chronic conditions for a progressive palliative care approach:a crosssectional study of prognostic indicators related to end-of-life trajectories. BMJ Open. 2016;6:e012340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5030552</ArticleId><ArticleId IdType="pubmed">27645556</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Batiste X, Espinosa J, Porta J, Benito E. Modelos de atenci&#xf3;n, organizaci&#xf3;n y mejora de calidad para la atenci&#xf3;n de enfermos avanzados terminales y sus familias:la aportaci&#xf3;n de los cuidados paliativos. Med Clin 2010;135:83-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20435322</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Batiste X, Espinosa J, Porta J, Benito E. Modelos de atenci&#xf3;n, organizaci&#xf3;n y mejora de calidad para la atenci&#xf3;n de enfermos avanzados terminales y sus familias:la aportaci&#xf3;n de los cuidados paliativos. Med Clin. 2010;135:83&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20435322</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS:a conspiracy of genes, environment and time. Nat Rev Neurol 2013;9:617-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS:a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Consejer&#xed;a de Sanidad. Generalitat Valenciana. Atenci&#xf3;n a Personas con Esclerosis Lateral Amiotr&#xf3;fica. 2019. URL:https://www.san.gva.es/documents/156344/8456968/Atencion_personas_con_ELA.pdf. Fecha &#xfa;ltima consulta:10.08.2022.</Citation></Reference><Reference><Citation>Consejer&#xed;a de Sanidad. Generalitat Valenciana. Atenci&#xf3;n a Personas con Esclerosis Lateral Amiotr&#xf3;fica. 2019.  URL: https://www.san.gva.es/documents/156344/8456968/Atencion_personas_con_ELA.pdf. Fecha &#xfa;ltima . consulta:10.08.2022.</Citation></Reference><Reference><Citation>OMS Step Safely:strategies for preventing and managing across the life-course. 2021. URL:https://www.who.int/publications/i/item/978924002191-4. Fecha &#xfa;ltima consulta:10.08.2022.</Citation></Reference><Reference><Citation>OMS Step Safely:strategies for preventing and managing across the life-course. 2021.  URL: https://www.who.int/publications/i/item/978924002191-4. Fecha &#xfa;ltima . consulta:10.08.2022.</Citation></Reference><Reference><Citation>OMS Ca&#xed;das 2021. URL:https://www.who.int/es/news-room/fact-sheets/detail/falls. Fecha &#xfa;ltima consulta:10.08.2022.</Citation></Reference><Reference><Citation>OMS Ca&#xed;das 2021.  URL: https://www.who.int/es/news-room/fact-sheets/detail/falls . Fecha &#xfa;ltima consulta:10.08.2022.</Citation></Reference><Reference><Citation>Schell WE, Mar VS, Da Silva CP. Correlation of falls in patients with amyotrophic lateral sclerosis with objective measures of balance, strength, and spasticity. NeuroRehabilitation. 2019;44:85-93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398543</ArticleId><ArticleId IdType="pubmed">30714981</ArticleId></ArticleIdList></Reference><Reference><Citation>Schell WE, Mar VS, Da Silva CP. Correlation of falls in patients with amyotrophic lateral sclerosis with objective measures of balance, strength, and spasticity. NeuroRehabilitation. 2019;44:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398543</ArticleId><ArticleId IdType="pubmed">30714981</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters TL, Weibull CE, Fang F, Sandler DP, Lambert PC, Ye W, et al. Association of fractures with the incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:419-25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5527744</ArticleId><ArticleId IdType="pubmed">28316249</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters TL, Weibull CE, Fang F, Sandler DP, Lambert PC, Ye W, et al. Association of fractures with the incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:419&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5527744</ArticleId><ArticleId IdType="pubmed">28316249</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, et al. An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis:a prospective multinational cohort study (GLOW). Ann Rheum Dis 2013;72:911-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886333</ArticleId><ArticleId IdType="pubmed">22730372</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, et al. An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis:a prospective multinational cohort study (GLOW) Ann Rheum Dis. 2013;72:911&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886333</ArticleId><ArticleId IdType="pubmed">22730372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol 2016;12:526-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2016;12:526&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloos AD, Bello-Haas VD, Thome R, Cassidy J, Lewis L, Cusma T, et al. Interrater and intrarater reliability of the Tinetti balance test for individuals with amyotrophic lateral sclerosis. Journal of Neurologic Physical Therapy 2004;28:12-9.</Citation></Reference><Reference><Citation>Kloos AD, Bello-Haas VD, Thome R, Cassidy J, Lewis L, Cusma T, et al. Interrater and intrarater reliability of the Tinetti balance test for individuals with amyotrophic lateral sclerosis. Journal of Neurologic Physical Therapy. 2004;28:12&#x2013;9.</Citation></Reference><Reference><Citation>Tu S, Wang C, Menke RAL, Talbot K, Barnett M, Kiernan MC, et al. Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2020;21:396-402.</Citation><ArticleIdList><ArticleId IdType="pubmed">32106716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu S, Wang C, Menke RAL, Talbot K, Barnett M, Kiernan MC, et al. Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">32106716</ArticleId></ArticleIdList></Reference><Reference><Citation>Manckoundia P, Mourey F, P&#xe9;rennou D, Pfitzenmeyer P. Backward disequilibrium in elderly subjects. Clin Interv Aging 2008;3:667-72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682399</ArticleId><ArticleId IdType="pubmed">19281059</ArticleId></ArticleIdList></Reference><Reference><Citation>Manckoundia P, Mourey F, P&#xe9;rennou D, Pfitzenmeyer P. Backward disequilibrium in elderly subjects. Clin Interv Aging. 2008;3:667&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682399</ArticleId><ArticleId IdType="pubmed">19281059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel P. Prevenci&#xf3;de caigudes en gent gran:efectivitat en la reducci&#xf3;de caigudes d'un programa d'intervenci&#xf3;f&#xed;sica basat en el programa d'exercicis OTAGO per gent gran de 75 a 90 anys residents a la comunitat. Projecte PRECIOSA 2021. Programa de Doctorat en Medicina. Barcelona:Universitat Aut&#xf2;noma de Barcelona;2021.</Citation></Reference><Reference><Citation>Gabriel P. Projecte PRECIOSA 2021. Programa de Doctorat en Medicina. Barcelona: Universitat Aut&#xf2;noma de Barcelona; 2021. Prevenci&#xf3;de caigudes en gent gran:efectivitat en la reducci&#xf3;de caigudes d'un programa d'intervenci&#xf3;f&#xed;sica basat en el programa d'exercicis OTAGO per gent gran de 75 a 90 anys residents a la comunitat.</Citation></Reference><Reference><Citation>Darb&#xe0;J. Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia:A population-based analysis. PLoS One 2019;14:e0223772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788732</ArticleId><ArticleId IdType="pubmed">31603947</ArticleId></ArticleIdList></Reference><Reference><Citation>Darb&#xe0; J. Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia:A population-based analysis. PLoS One. 2019;14:e0223772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788732</ArticleId><ArticleId IdType="pubmed">31603947</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis:guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis:guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:921&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al;EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS guidelines on the clinical management of ALS- revised report of EFNS task force. Eur J Neurol 2012;19:360-75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS guidelines on the clinical management of ALS- revised report of EFNS task force. Eur J Neurol. 2012;19:360&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Haas VD. Physical therapy for individuals with amyotrophic lateral sclerosis:current insights. Degener Neurol Neuromuscul Dis 2018;8:45-54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065609</ArticleId><ArticleId IdType="pubmed">30890895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Haas VD. Physical therapy for individuals with amyotrophic lateral sclerosis:current insights. Degener Neurol Neuromuscul Dis. 2018;8:45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065609</ArticleId><ArticleId IdType="pubmed">30890895</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Bernardi-Ojuel L, Torres-Collado L, Garc&#xed;a-de-la-Hera M. Occupational therapy interventions in adults with multiple sclerosis or amyotrophic lateral sclerosis:a scoping review. Int J Environ Res Public Health 2021;18:1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7913738</ArticleId><ArticleId IdType="pubmed">33546507</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Bernardi-Ojuel L, Torres-Collado L, Garc&#xed;a-de-la-Hera M. Occupational therapy interventions in adults with multiple sclerosis or amyotrophic lateral sclerosis:a scoping review. Int J Environ Res Public Health. 2021;18:1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7913738</ArticleId><ArticleId IdType="pubmed">33546507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez S, Mar&#xed;n BI. An&#xe1;lisis de la evidencia desde terapia ocupacional:m&#xe9;todos de valoraci&#xf3;n y tratamiento en esclerosis lateral amiotr&#xf3;fica. Rev Astur Ter Ocu 2014;11:24-31.</Citation></Reference><Reference><Citation>Rodr&#xed;guez S, Mar&#xed;n BI. An&#xe1;lisis de la evidencia desde terapia ocupacional:m&#xe9;todos de valoraci&#xf3;n y tratamiento en esclerosis lateral amiotr&#xf3;fica. Rev Astur Ter Ocu. 2014;11:24&#x2013;31.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>